Other OpenAI introduces GPT-Rosalind, its drug discovery AI PharmaphorumIn this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.OtherRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaphorum In this week’s second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin. OtherRead full story Post navigation Previous: Novo may have muscle advantage over Lilly in weight-loss race: preprintNext: RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media Related Stories Other Takeda and Weave Bio collaborate on AI-driven automation in drug development pharminent September 2, 2026 Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026